Triumvira Immunologics

North America Legal Chronicle. January 24, 2023

Triumvira Immunologics’ Partnership with Merck to Evaluate TAC01-HER2 Cell Therapy

By Sonia Carcano

Torys LLP acted as counsel to Triumvira Immunologics on the collaboration with Merck. On January 5, 2023, Triumvira Immunologics, Inc. (“Triumvira”) announced a clinical trial collaboration...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

North America Legal Chronicle. March 22, 2022

Triumvira Immunologics’ $100 Million Series A Financing Round

By Laura Testa

Latham & Watkins, Torys LLP and Goodwin represented Triumvira Immunologics in the transaction. Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Berkshire Partners’ $7.8 Billion Closing of Berkshire Fund XI

Francisco Partners’ Investment in Evite

Improving’s Acquisition of Leniolabs

San Miguel’s $28.2 Million Sustainability-Linked Notes Offering

Companhia Jaguari de Energia’s R$300 Million Unsecured Debentures Issuance

Pampa Energía’s US$84 Million Notes Issuance

Bright Software Group’s Acquisition Of Anglia Registrars (Inform Direct)

Infortar’s Acquisition of Tallinna Raamatutrükikoda

Brookfield’s $2.3 Billion Acquisition Of Minority Stakes In Four UK Offshore Wind Farms From Ørsted

Camusat Holding’s €81 Million Mezzanine Investment Round

Retail Holding’s Shareholders Reconfiguration

Ora Developers Egypt for Real Estate Investment’s Financing Round

Kokshetau Hospital’s €365 Million PPP Financing

Fourth Milling Company’s Initial Public Offering on Tadawul

A101 Yeni Magazacilik A.S.’ $200 Million Sustainability Loan

Waaree Energies’ $515 Million IPO

Bureau Veritas’ Acquisition Of The APP Group From Five V Capital

Pilbara’s Revolving Credit Facility

High-Profile Employment Litigator Joins Polsinelli in D.C.

O’Melveny Welcomes Experienced Houston Energy Lawyer David Aaronson

Paul Hastings Enhances Premier Private Equity and M&A Platform with New York Finance Partner

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

High-Profile Employment Litigator Joins Polsinelli in D.C.

O’Melveny Welcomes Experienced Houston Energy Lawyer David Aaronson

Paul Hastings Enhances Premier Private Equity and M&A Platform with New York Finance Partner

Triumvira Immunologics’ Partnership with Merck to Evaluate TAC01-HER2 Cell Therapy

Standard 1 Year Membership Required

Triumvira Immunologics’ $100 Million Series A Financing Round

Standard 1 Year Membership Required